Global ENT devices market: 7% CAGR between 2012-2016

Press Release   •   Feb 26, 2013 10:50 GMT

The Global ENT Devices market is to grow at a CAGR of 7.37 percent over the period 2012-2016. One of the key factors contributing to this market growth is the advancements in the Cochlear Implant Devices segment. The Global ENT Devices market has also been witnessing an increase in the number of acquisitions and new entrants. However, problems with voice prosthesis and hearing aid device batteries could pose a challenge to the growth of this market.

The Global ENT Devices market has been experiencing significant growth in the Rechargeable Hearing Aid Devices segment recently. For instance, Hansaton Acoustics Inc. introduced the AQ Custom Rechargeable ITE in 2010 and the AQ X-Mini Rechargeable Receiver-in-the-Canal (RIC) device in July 2011. Sales of rechargeable consumer hearing aid devices possess many advantages compared to the conventional hearing aid devices with primary cells. Rechargeable hearing aid devices are smaller in size, allowing manufacturers to build very small, cosmetically appealing, hearing instruments. Moreover, these rechargeable hearing aid devices are environmentally friendly and easy to use. Further, the quality and the battery life of these devices is estimated to be better compared to the primary cells.

Most of the leading ENT devices manufacturers are customizing and developing their product lines to appeal more to consumers and stay ahead of the competition. Several ENT devices vendors are addressing the needs of older citizens by developing products that increase the quality of digital hearing aid devices, nasal splints, and voice prosthesis. Moreover, many patients who suffer from both hearing loss and tinnitus might benefit from products such as the Advanced HiRes 90K Implant. Furthermore, manufacturers are developing cosmetically appealing ENT devices to target the younger population. This increase in product customization is expected to drive the growth of the Global ENT Devices market during the forecasted period.

The key vendors dominating this market space are Cochlear Ltd., Siemens Healthcare, Sonova Holding AG, Starkey Laboratories Inc., Widex A/S, and William Demant Holding A/S. The other vendors mentioned in the report are GN ReSound A/S, Unitron Hearing Inc., Sonic Innovations Inc., Panasonic Corp., Rexton Inc., Beltone, Miracle-Ear Inc., MED-EL GmbH, Neurelec SA, Nuear Hearing Aids Inc., Bernafon, American Hearing Systems Inc., Audiosync Inc., Zounds Inc., and Avada Hearing Care.

For more information on the Global ENT devices market, please click here: Global ENT devices market issues news updates and report summaries covering all major industries and sectors. The service provides additional client monitoring and timely alerts to breaking industry and sector news leading the day's business headlines. News articles, written by our staff, contain additional analyst insight, providing value added insight for our readers. News updates and real-time alerts on newly-released market reports are also available from our Facebook page, Twitter feed @CandMResearch and RSS links. We also welcome inquiries from business journalists and the news media.